In a rapidly evolving medical device industry, the upcoming Medical Device User Fee Amendments VI (MDUFA VI) holds the promise of transformative change. Positioned as a vital component in the regulatory landscape, MDUFA VI is set to redefine the dynamics of device regulation through strategic
In today's interview, we dive into the monumental changes happening within the CDC’s vaccine recommendation committee. We are joined by James Maitland, though not directly involved, his insights into regulatory and policy changes are incredibly valuable due to his extensive expertise in technology
In a time when the role of private equity in healthcare is under intense scrutiny, Oregon's recently signed law represents a significant regulatory shift aimed at preventing non-physician investments in medical practices. To unpack the complexities and implications of this law, we spoke with James
The medical device industry, encompassing areas like ventilators, plays a crucial role in modern healthcare by providing essential technologies that sustain life. Recent developments regarding Medtronic's decision to recall over 4,800 ventilators illuminate persisting challenges within this sector.
In a rapidly evolving healthcare landscape where access to affordable insurance hangs in the balance, a GOP healthcare bill has sparked intense debate across the United States. As state exchange directors rally in opposition, the question looms: Can this legislative effort withstand the mounting
Recent legislation has stirred significant concern among healthcare analysts regarding its potential to dramatically reshape market trends and patient access. The budget reconciliation bill, which seeks substantial amendments to Medicaid and the Affordable Care Act (ACA) exchanges, could leave
